Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimavanserin in Parkinson's Disease Psychosis
NCT00477672Phase 3Completed
- Sponsor
- Acadia Pharmaceuticals
- Start
- Jun 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of pimavanserin in Parkinson's disease (PD), sponsored by Acadia Pharmaceuticals. Started Jun 2007; status: completed.
02
Drugs
pimavanserin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00477672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00477672.